Company news
Ctt Pharmaceutical Holdings, Inc. (OTC:CTTH) news
Ctt Pharmaceutical Holdings, Inc. news releases on 6ix. Latest, Aug 18, 2026: CTT Pharma Files a Patent Continuation with the U.S. Patent Office
Press releases & updates
CTT Pharma Files a Patent Continuation with the U.S. Patent Office
August 18, 2026
CTT Pharma Receives U.S. Patent Approval for Nicotine, Vitamins, and Caffeine Delivery Technology
August 10, 2026
CTT Pharma Receives SEC Approval
August 5, 2026
CTT Pharma Signs LOI for Clinical Trials and Testing of Nicotine Products
June 22, 2026
CTT Pharma Signs LOI with European Company
May 14, 2026
CTT Pharmaceutical Holdings, Inc. Files Form S-1 Registration Statement and Advances Equity Line of Credit and Scientific Development Milestones
December 30, 2025
CTT Pharma's Scientists Publish Peer-Reviewed Paper in the Journal of Drug Delivery and Therapeutics
December 16, 2025
CTT Pharma CEO Issues Letter to Shareholders
December 2, 2025
CTT Pharma's CEO Will Issue a Letter to Shareholders
November 20, 2025
CTT Pharma's CEO will issue a Letter to Shareholders
November 20, 2025
CTT Pharma Signs Contract for $3 Million Equity Line of Credit
September 10, 2025
CTT Pharma Grant Updates
June 10, 2025
OTC Markets Group Welcomes New OTCQB Companies – March 17
March 17, 2025
CTT Pharma's CEO Issues Letter to Shareholders
March 11, 2025
CTT Pharma Uplists to the OTCQB Today
March 9, 2025
CTT Pharmaceuticals Holdings, Inc. Announces Uplisting to OTCQB Market Trading
March 4, 2025
CTT Pharma Gives Uplisting Update
March 2, 2025
CTT Pharma Gives Update On U.S. and European Patents
February 24, 2025
CTT Pharma Gives Update On U.S. and European Patents
February 25, 2025
CTT Pharma Gives Update On NSF Grant
February 11, 2025
CTT Pharma Adds Independent Director With NIH/NSF Experience
February 4, 2025
CTT Pharma Reduces Authorized Share Count
February 2, 2025
CTT Pharma Submits Proposal for NIH Grant
January 29, 2025
Retransmission: CTT Pharma and Johns Hopkins University Submits Proposal for $15 Million NIH Grant for Smoking Cessation
January 27, 2025
CTT Pharma has engaged The OTC Markets to Uplist to The OTCQB
January 21, 2025
CTT Pharma will issue a news release January 22, 2025
January 20, 2025
CTT Pharma and Johns Hopkins University Submit Proposal for $15 Million NIH Grant For Smoking Cessation
January 6, 2025
CTT Pharma Update
January 5, 2025
CTT Pharma's CEO Speaks At FDA/NIH Meeting for Advancing Smoking Cessation
November 3, 2024
CTT Pharmaceuticals Holdings, Inc. Successfully Completes 2 Year PCAOB Audit
August 21, 2024
CTT Pharma Signs Contract for PCAOB Audit
July 15, 2024
CTT Pharma gives update on NSF Grant for Smoke Reduction Technology
June 23, 2024
CTT Pharma Updates On Diabetes Drug Grant
May 14, 2024
CTT Pharma CEO Announces 8.1% Stock Ownership In Company
May 13, 2024
CTT Pharma and Johns Hopkins University Partner for $15 Million NIH Grant
May 7, 2024
CTT Pharma News Release
October 29, 2023
CTT Pharma Appoints David Paton, former Head Of Innovation at BAT, as Senior Advisor
March 27, 2023
CTT Pharma Corporate Updates
January 29, 2023
CTT Parma Updates On Worldwide Patent Portfolio
December 18, 2022
CTT Pharma Signs Agreement for New Oral Product Development
December 5, 2022
CTT Pharma's Europe Patent Approved
December 4, 2022
CTT Pharma's CEO Issues Letter To Shareholders
December 4, 2022
CTT Pharma Settles Lawsuit With Aurora
December 1, 2022
CTT Pharma Will Utilize Patented Technology for Additional Oral Products
November 30, 2022
CTT Enters into Business Development Partnership with 3 Rivers Biotech
September 8, 2020
CTT Pursues Expansion Into New Industry Verticals and the United States with Business Development Appointments
September 1, 2020
CTT Pharma Files Statement of Claim against Aurora Cannabis and Appoints Dr. Shane Morris to Advisory Board
August 27, 2020
CTT Pharmaceuticals provides Corporate Update
December 23, 2019
CTT Pharma Strengthens Board and Management Team
November 27, 2019
Aurora Cannabis and CTT Pharmaceutical Announce Launch of Sublingual Cannabis Wafers
October 8, 2019